概括
自身免疫性小脑缩症和运动障碍涉及各种抗体和症状. 早期识别红旗和面板测试有助于诊断这些可治疗的疾病.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经免疫学 神经免疫学
背景情况:
- 自身免疫性小脑缩症和运动障碍呈现出各种各样的临床综合征.
- 在受影响的患者中发现了一系列不断扩大的神经元抗体.
- 这些疾病往往是可以治疗的,因此需要将它们纳入差异诊断.
研究的目的:
- 审查自身免疫大脑动症和其他自身免疫运动障碍的临床和抗体谱.
- 突出特征的表型和诊断红旗.
- 讨论如何将这些罕见疾病纳入临床实践.
主要方法:
- 临床和抗体数据在自身免疫大脑动和运动障碍的审查.
- 识别特征的表型和红旗.
- 讨论诊断方法和差异诊断.
主要成果:
- 越来越多地发现了新的神经抗体,包括KLHL11,SEPT3,SEPT5,TRIM9,TRIM46和TRIM67.
- 与IgLON5抗体相关的综合征是神经退行性疾病的重要考虑因素.
- 奥普索克隆斯-肌克隆斯综合征是与SARS-CoV-2相关的关键类型传染性运动障碍.
结论:
- 临床专业知识对于识别需要神经元抗体检测的患者至关重要.
- 由于表型-抗体重叠,建议对血清和脑脊液进行小组测试.
- 早期诊断和治疗自身免疫运动障碍可以改善患者的结果.
相关概念视频
Autoimmune Disorders
404
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
404
Disorders of the Skeletal Muscle
920
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
920
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Gastrointestinal Motility Disorders
323
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
323
Myasthenia Gravis: Diagnostic Tests
730
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
730
Parkinson's Disease: Overview
510
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
510


